Renalytix Plc
RNLX · NASDAQ
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $14 | $120 | $83 | $1,093 |
| - Cash | $5 | $25 | $41 | $65 |
| + Debt | $9 | $12 | $13 | $0 |
| Enterprise Value | $17 | $107 | $55 | $1,029 |
| Revenue | $2 | $3 | $3 | $1 |
| % Growth | -32.7% | 14.6% | 99.2% | – |
| Gross Profit | $0 | $1 | $1 | $1 |
| % Margin | 6.8% | 20.6% | 30.9% | 46.1% |
| EBITDA | -$29 | -$42 | -$53 | -$36 |
| % Margin | -1,246% | -1,225.8% | -1,774.2% | -2,381.2% |
| Net Income | -$33 | -$46 | -$45 | -$35 |
| % Margin | -1,461.6% | -1,340.2% | -1,524.4% | -2,329% |
| EPS Diluted | -0.62 | -1.1 | -1.34 | -0.98 |
| % Growth | 43.6% | 17.9% | -36.7% | – |
| Operating Cash Flow | -$30 | -$33 | -$46 | -$25 |
| Capital Expenditures | -$0 | $0 | -$1 | -$2 |
| Free Cash Flow | -$30 | -$33 | -$46 | -$26 |